Described herein are adjuvants containing as the activeingredient an attenuated toxin having a residual activity of at least1/2000 the activity of the natural toxin and vaccines containing suchadjuvants. By using, for example, attenuated natural cholera toxin,vaccines capable of showing sufficient immune potentiation inpercutaneous vaccination or nasal vaccination can be presented.